| Treatment of advanced HER2-positive breast cancer: 2018 and beyond N Pondé, M Brandão, G El-Hachem, E Werbrouck, M Piccart Cancer treatment reviews 67, 10-20, 2018 | 147 | 2018 |
| Genomic and transcriptomic analyses of breast cancer primaries and matched metastases in AURORA, the Breast International Group (BIG) molecular screening initiative P Aftimos, M Oliveira, A Irrthum, D Fumagalli, C Sotiriou, EN Gal-Yam, ... Cancer discovery 11 (11), 2796-2811, 2021 | 101 | 2021 |
| Biomarkers of response and resistance to PI3K inhibitors in estrogen receptor-positive breast cancer patients and combination therapies involving PI3K inhibitors M Brandao, R Caparica, D Eiger, E de Azambuja Annals of oncology 30, x27-x42, 2019 | 75 | 2019 |
| Impact of solid cancer on in-hospital mortality overall and among different subgroups of patients with COVID-19: a nationwide, population-based analysis E De Azambuja, M Brandão, H Wildiers, A Laenen, S Aspeslagh, ... ESMO open 5 (5), e000947, 2020 | 74 | 2020 |
| Combination therapies for the treatment of HER2-positive breast cancer: current and future prospects M Brandão, NF Pondé, F Poggio, N Kotecki, M Salis, M Lambertini, ... Expert review of anticancer therapy 18 (7), 629-649, 2018 | 47 | 2018 |
| Mammaprint™: a comprehensive review M Brandão, N Pondé, M Piccart-Gebhart Future oncology 15 (2), 207-224, 2019 | 42 | 2019 |
| VISTA: a promising target for cancer immunotherapy? M Tagliamento, E Agostinetto, R Borea, M Brandão, F Poggio, A Addeo, ... ImmunoTargets and Therapy, 185-200, 2021 | 39 | 2021 |
| What is the real impact of estrogen receptor status on the prognosis and treatment of HER2-positive early breast cancer? M Brandão, R Caparica, L Malorni, A Prat, LA Carey, M Piccart Clinical Cancer Research 26 (12), 2783-2788, 2020 | 37 | 2020 |
| Cervical cancer screening uptake in women aged between 15 and 64 years in Mozambique M Brandão, S Tulsidás, A Damasceno, C Silva-Matos, C Carrilho, N Lunet European Journal of Cancer Prevention 28 (4), 338-343, 2019 | 27 | 2019 |
| Clinical implications of body mass index in metastatic breast cancer patients treated with abemaciclib and endocrine therapy MA Franzoi, D Eiger, L Ameye, N Ponde, R Caparica, C De Angelis, ... JNCI: Journal of the National Cancer Institute 113 (4), 462-470, 2021 | 25 | 2021 |
| Computed tomography-based analyses of baseline body composition parameters and changes in breast cancer patients under treatment with CDK 4/6 inhibitors MA Franzoi, C Vandeputte, D Eiger, R Caparica, M Brandão, ... Breast cancer research and treatment 181, 199-209, 2020 | 25 | 2020 |
| Cancer incidence in Mozambique in 2015–2016: data from the Maputo Central Hospital cancer registry C Carrilho, F Fontes, S Tulsidás, C Lorenzoni, J Ferro, M Brandão, ... European Journal of Cancer Prevention 28 (4), 373-376, 2019 | 25 | 2019 |
| Systemic treatment of patients with early breast cancer: recent updates and state of the art R Caparica, M Brandão, M Piccart The Breast 48, S7-S20, 2019 | 24 | 2019 |
| Survival impact and cost-effectiveness of a multidisciplinary tumor board for breast cancer in Mozambique, Sub-Saharan Africa M Brandão, A Guisseve, G Bata, J Firmino-Machado, M Alberto, J Ferro, ... The oncologist 26 (6), e996-e1008, 2021 | 22 | 2021 |
| Impact of HIV infection on baseline characteristics and survival of women with breast cancer M Brandão, M Bruzzone, MA Franzoi, C De Angelis, D Eiger, R Caparica, ... Aids 35 (4), 605-618, 2021 | 21 | 2021 |
| Endocrine therapy-based treatments in hormone receptor-positive/HER2-negative advanced breast cancer: systematic review and network meta-analysis M Brandão, C Maurer, PK Ziegelmann, NF Pondé, A Ferreira, S Martel, ... ESMO open 5 (4), e000842, 2020 | 20 | 2020 |
| Breast cancer subtypes: implications for the treatment and survival of patients in Africa—a prospective cohort study from Mozambique M Brandão, A Guisseve, G Bata, M Alberto, J Ferro, C Garcia, C Zaqueu, ... ESMO open 5 (5), e000829, 2020 | 20 | 2020 |
| Cardiotoxicity of trastuzumab given for 12 months compared to shorter treatment periods: a systematic review and meta-analysis of six clinical trials D Eiger, MA Franzoi, N Pondé, M Brandão, C De Angelis, MS Nogueira, ... ESMO open 5 (1), e000659, 2020 | 17 | 2020 |
| Healthcare use and costs in early breast cancer: a patient-level data analysis according to stage and breast cancer subtype M Brandão, S Morais, L Lopes-Conceição, F Fontes, N Araújo, T Dias, ... ESMO open 5 (6), e000984, 2020 | 16 | 2020 |
| Satisfação com a especialidade entre os internos da formação específica em Portugal MJ Martins, I Laíns, B Brochado, M Oliveira-Santos, P Pinto Teixeira, ... Acta Médica Portuguesa 28 (2), 209-221, 2015 | 16 | 2015 |
